About the Procedure
Brigham and Women’s Hospital Cardiac and Vascular Surgeons Demonstrate Minimally Invasive Repair of Thoracic Aortic Aneurysm
Boston, MA – On May 22, at 4:30 p.m. E.T., leading cardiac and vascular surgeons from Brigham and Women’s Hospital will webcast a live minimally invasive endovascular thoracic aortic stent-graft repair.
A thoracic aortic aneurysm is a widening or bulging of part of the wall of the aorta within the chest – the body’s largest artery. The risk factors for thoracic aneurysms include atherosclerosis, hypertension, and a history of smoking. Treatment of thoracic aortic aneurysm traditionally involves surgery to replace the damaged portion of the aorta with polyester graft. Recently developed as an alternative to the conventional open surgical repair, which requires a major operation with the possibility of complications, and a long recovery, endovascular stent-graft repair offers a new less invasive alternative for thoracic aneurysm repair with less risk of complications, decreased blood loss, and a faster recovery.
For this webcast, operating surgeons Michael Belkin, MD, Chief of Vascular and Endovascular Surgery, Michael J. Davidson, MD, cardiac surgeon, and Ed Gravereaux, vascular surgeon, will demonstrate an endovascular stent-graft repair of a thoracic aortic aneurysm, performed through the vessels in the groin. R. Morton Bolman III, MD, Chief of Cardiac Surgery will narrate during the procedure and respond to email questions from viewers.
“Endovascular stent-graft repair provides additional options for patients with thoracic aortic aneurysm,” said Dr. Bolman. “This webcast provides both doctors and patients with a convenient forum for an interactive exchange of questions, ideas, and opinions,” said Dr. Bolman.
To view this BWH webcast and others click here.
See the latest news from Brigham and Women’s Hospital.
Brigham and Women’s Hospital (BWH) is a 747-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare System, an integrated health care delivery network. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 800 physician-investigators and renowned biomedical scientists and faculty supported by more than $400M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit www.brighamandwomens.org.